Table 1.
LOH and Clonality Analyses of TSC Lesions[Note]
Allele Status at |
|||||||||||||||
Patient (Sex) | Inheritance | Germline Mutation | TumorType | D16S663 | D16S665 | Kg8 | Exon 40 | TSC2GLM | D16S525 | D9S2126 | D9S1830 | TSC1GLM | D9S1199 | D9S1198 | Clonality |
1 (F) | Sporadic | TSC1, exon 15 (1711delTG,V497fs→503X) | UF | NI | NI | H | H | NA | NI | H | H | H | H | NI | NI |
2 (F) | Sporadic | TSC1, exon 15 (2148C→T, Q655X) | AML | H | NI | H | NI | NA | NI | NI | H | LOHa | LOH | LOH | C |
3 (M) | Sporadic | TSC1, exon 15 (2104T→A, L628X) | SEGA | H | NI | NI | NI | NA | NI | H | H | Ha | H | H | NA |
4 (F) | Familial | TSC2, intron 1, splice donor (138+1G→A) | SEGA | H | H | NI | LOH | LOHa | LOH | NI | H | NA | NI | H | NT |
5 (F) | Sporadic | TSC2, exon 30, 3685–3700del (Q1229fs→1296X) | Rhabdo | NI | H | NI | NI | H | NI | H | NI | NA | NI | H | NI |
6 (M) | Sporadic | TSC2, exon 12 (1348G→T, E450X) | Rhabdo | H | NI | NI | NI | Ha | NI | NI | H | NA | H | H | NA |
7 (F) | Sporadic | TSC2, exon 36 (4743delC, L1581fs→158Xb) | AML | H | H | H | NI | NAc | LOH | H | H | NA | H | H | C |
8 (F) | Familial | TSC2, exon 19 (2109G→A, W703X) | LAM 1 | H | H | H | NI | Ha | NI | H | NI | NA | H | H | P |
LAM 2 | H | H | H | NI | Ha | NI | H | NI | NA | H | H | P | |||
LAM 3 | H | H | H | NI | Ha | NI | H | NI | NA | H | H | P | |||
9 (F) | Sporadic | TSC2, exon 33 (4207delG, D1400fs→1410X) | AML 1 | NI | LOH | LOH | NI | LOH | NI | NI | H | NA | H | NI | C |
AML 2 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
Tuber 1 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | C | |||
Tuber 2 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
Tuber 3 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
Tuber 4 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
Tuber 5 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | S | |||
SEGA 1 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | S | |||
SEGA 2 | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
UF | NI | H | H | NI | H | NI | NI | H | NA | H | NI | C | |||
GP | NI | H | H | NI | H | NI | NI | H | NA | H | NI | P | |||
10 (F) | Sporadic | Not detected | AML 1 | LOH | LOH | NI | NI | NA | LOH | H | H | NA | NI | H | P |
AML 2 | LOH | LOH | NI | NI | NA | LOH | H | H | NA | NI | H | C | |||
AML 3 | LOH | LOH | NI | NI | NA | LOH | H | H | NA | NI | H | P |
Note.— Rhabdo = cardiac rhabdomyoma; GP = gastric polyp; GLM = germline mutation point; NI = not informative; H = heterozygous; NA = not applicable; NT = not tested owing to sample quantity; C = clonal; P = polyclonal; S = significantly skewed toward one allele.
Allelic status at the GLM was assessed by SSCP/sequencing, and only definite losses were scored as LOH; the remaining cases are scored as H, since allelic loss can be ambiguous if determined by SSCP or sequencing analysis.
Somatic mosaicism.
Owing to mosaicism.